TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 2 | 0 | -1 | 3 | 3 | -3 | 0 | 1 |
S | %wins | 100 | 100 | 0 | 0 | 100 | 60 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/12/24 16:30 | 7/10/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Pruden Gary J | MA | D | S | -1,191 | 95.04 | 0 | -13 | -35 | 23 | I | |||||||||||||||
3/8/19 16:32 | 3/6/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Pruden Gary J | MA | D | S | -73 | 22.77 | 0 | -3 | -24 | 10 | D | |||||||||||||||
3/2/17 17:16 | 2/28/17 | JNJ | Johnson & Johnson | NJ | Health | Drug | Pharmaceutical Preparations | Pruden Gary J | NJ | O | EVP,WW C | S | -1,992 | 122.21 | 33 | -16 | -27 | 44 | D | 27 | 19 | 5 | 10 | 9 | 10 | 5 | 1 | 0 | 0 | 1 | |||
6/9/16 16:12 | 6/7/16 | JNJ | Johnson & Johnson | NJ | Health | Drug | Pharmaceutical Preparations | Pruden Gary J | NJ | O | EVP,WW C | S | -1,130 | 116.03 | 33 | -10 | -18 | 44 | D | 19 | 21 | 14 | 9 | 3 | 3 | 2 | 1 | 0 | -1 | 5 | 3 | -3 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |